Cargando…
Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients
Major depressive disorder (MDD) is a leading cause of disability worldwide and results tragically in the loss of almost one million lives in Western societies every year. This is due to poor understanding of the disease pathophysiology and lack of empirical medical tests for accurate diagnosis or fo...
Autores principales: | Martins-de-Souza, D, Guest, P C, Harris, L W, Vanattou-Saifoudine, N, Webster, M J, Rahmoune, H, Bahn, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309534/ https://www.ncbi.nlm.nih.gov/pubmed/22832852 http://dx.doi.org/10.1038/tp.2012.13 |
Ejemplares similares
-
Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012) -
The role of proteomics in depression research
por: Martins-de-Souza, Daniel, et al.
Publicado: (2009) -
Proteomic analysis of post mortem brain tissue from autism patients: evidence for opposite changes in prefrontal cortex and cerebellum in synaptic connectivity-related proteins
por: Broek, Jantine AC, et al.
Publicado: (2014) -
Serum proteomic profiling of major depressive disorder
por: Bot, M, et al.
Publicado: (2015) -
Biological and psychosocial risk factors for psychotic major depression
por: Heslin, M., et al.
Publicado: (2015)